Scientists Make Old Blood Stem Cells Act Young Again
Key takeaways:
-
Aging blood‑forming stem cells develop overactive, overly acidic lysosomes that disrupt metabolism, epigenetic stability, and immune balance.
-
Blocking this lysosomal hyperactivity reset old HSCs to a more youthful state, improving their capacity to regenerate balanced blood and immune cells.
-
An ex vivo treatment boosted the blood‑forming capacity of old stem cells more than eightfold, hinting at future strategies to support healthier blood and immune systems with age.
How lysosomes drive stem cell aging
Lysosomes are often described as the cell’s recycling plants: they break down worn‑out proteins, lipids, and other components, store nutrients, and help balance the cell’s energy economy. In young stem cells, lysosomes help keep metabolism and cellular “housekeeping” in check. In this study, scientists found that in aged HSCs, lysosomes become too acidic, damaged, and hyperactive. That overactivity throws off metabolic balance and destabilizes epigenetic patterns—changes that push stem cells toward dysfunction.
The team used single‑cell transcriptomics and functional tests to show that these lysosomal defects were tightly linked to loss of regenerative capacity. Old HSCs with hyperactive lysosomes struggled to make balanced blood and immune cells and showed signs of chronic inflammatory signaling, a hallmark of aging at the cellular level.
Turning back the clock on old blood stem cells
To see whether these changes were reversible, the researchers used a vacuolar ATPase inhibitor, a compound that slows the proton pumps that acidify lysosomes. When aging HSCs were treated with this inhibitor, lysosomal acidity and activity moved back toward youthful levels. Strikingly, the treated old stem cells regained key youthful traits: they produced more balanced blood and immune cells, generated new healthy stem cells, and showed better mitochondrial function and healthier epigenetic profiles.
The intervention also tamped down inflammation. Healthier lysosomes improved how cells processed mitochondrial DNA, which in turn reduced activation of the cGAS‑STING pathway—an immune sensor that can drive inflammation when mis‑triggered. By calming this pathway, the treatment lowered harmful inflammatory signals that can damage tissues and further erode stem cell function.
Big jump in blood‑forming capacity
The researchers then tested an ex vivo approach, treating old stem cells outside the body and then returning them to animals. After this lysosome‑targeted treatment, the blood‑forming ability of old HSCs in vivo increased more than eightfold, a dramatic improvement in their regenerative performance. In practical terms, these “reset” stem cells were far better at rebuilding the blood system compared with untreated aged cells.
That level of enhancement highlights lysosomal dysfunction as a central, actionable driver of stem cell aging, not just a side effect. It suggests that carefully tuning lysosomal activity could become a powerful lever for restoring function in aged blood and immune systems.
What this could mean for future therapies
Although this work was done in mice and in stem cells treated outside the body, it points to several future directions. Targeting lysosomal hyperactivity might one day help:
-
Maintain healthier blood and immune systems in older adults
-
Improve stem cell transplants by rejuvenating donor or patient cells before infusion
-
Support gene therapies, by starting from more robust, less-inflamed stem cells
The study also feeds into a broader theme in aging research: many age‑related changes are not completely irreversible, at least at the cellular level. By identifying and correcting key failure points—here, overactive, overly acidic lysosomes—researchers can sometimes restore youthful function in old cells. Whether similar lysosome‑targeted strategies will translate safely and effectively to humans is still unknown, but this work marks a significant step toward that goal.
References:
- Tasleem Arif, Jiajing Qiu, Hossein Khademian, Anusree Lohithakshan, Anagha Menon, Vijay Menon, Mary Slavinsky, Maxime Batignes, Miao Lin, Robert Sebra, Kristin G. Beaumont, Deanna L. Benson, Nikolaos Tzavaras, Mickaël M. Ménager, Saghi Ghaffari. Reversing lysosomal dysfunction restores youthful state in aged hematopoietic stem cells. Cell Stem Cell, 2025; 32 (12): 1904 DOI: 10.1016/j.stem.2025.10.012